Condition: Arteriovenous Malformations · Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Cerebral and medullary arteriovenous malformations (AVMs) lead to arterial and venous networks to communicate pathologically, creating an arteriovenous shunt. The occurrence of intracranial haemorrhage is the most important prognostic factor of AVMs because it is associated with a significant morbidity and mortality. The genetic, molecular and cellular mechanisms that cause vascular malformations of the central nervous system are partially known and the influence of genetic damage on the prognosis of AVMs is poorly known.
This description comes directly from the study's public registry record.
Stanislas Smajda, MD · 0148036454 · ssmajda@for.paris
Amélie Yavchitz, MD · 0148036454 · ayavchitz@for.paris
Always discuss trial participation with your own doctor first.
| HOPITAL FONDATION Adolphe de ROTHSCHILD | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04772963